Literature DB >> 3009327

Nonpharmacological approaches to the control of high blood pressure. Final report of the Subcommittee on Nonpharmacological Therapy of the 1984 Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure.

.   

Abstract

This report reviews a variety of nonpharmacological approaches used to control arterial blood pressure. Of all the modalities considered, only three had sufficient scientific support to warrant recommendation for inclusion in hypertension treatment programs. Each of these three modalities--weight control, alcohol restriction, and sodium restriction--was found to be capable not only of independently controlling blood pressure (particularly in patients with mild hypertension) but also of reducing the number and dosage of prescribed pharmacological agents, should their prescription be indicated. Weight reduction was found to reduce the risk from elevated arterial pressure as well as overall cardiovascular morbidity and mortality. However, because the rate of recidivism was exceedingly high in these studies, close and continuous patient follow-up is considered necessary. Excessive alcohol intake is associated in many studies with proportionally higher arterial pressures and an increased prevalence of hypertension. Therefore, the recommendation of moderation in alcohol consumption to less than 2 oz of ethanol daily for patients with hypertension is supported. Restriction of dietary sodium to less than 2 g/day was the only other nonpharmacological approach with sufficient support to be recommended as a treatment for hypertension. Although long-term studies are sorely lacking, sodium restriction has been shown to be manageable and safe and probably will benefit those hypertensive patients who are sodium-sensitive.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3009327

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  11 in total

1.  Hypertension research program at ochsner: a program in translational research.

Authors:  Edward Frohlich
Journal:  Ochsner J       Date:  2002

Review 2.  Sirtuins and their relevance to the kidney.

Authors:  Chuan-Ming Hao; Volker H Haase
Journal:  J Am Soc Nephrol       Date:  2010-07-01       Impact factor: 10.121

3.  [Salt and blood pressure].

Authors:  F H Epstein
Journal:  Soz Praventivmed       Date:  1986

4.  Effect of antihypertensive formulation on health service expenditures.

Authors:  D A Sclar; T L Skaer; L M Robison; A Chin; M P Okamoto; R K Nakahiro; M A Gill
Journal:  Clin Auton Res       Date:  1993-12       Impact factor: 4.435

Review 5.  Physical activity in older adults. An overview of health benefits.

Authors:  L S Pescatello; L DiPietro
Journal:  Sports Med       Date:  1993-06       Impact factor: 11.136

6.  Behavioral treatment of isolated systolic hypertension in the elderly.

Authors:  L K Pearce; B T Engel; J R Burton
Journal:  Biofeedback Self Regul       Date:  1989-09

7.  The effects of thermal biofeedback and autogenic training of cardiovascular reactivity: the joint USSR-USA Behavioral Hypertension Treatment Project.

Authors:  E B Blanchard; G C McCoy; R J McCaffrey; D A Wittrock; A Musso; M Berger; T A Aivasyan; V V Khramelashvili; B B Salenko
Journal:  Biofeedback Self Regul       Date:  1988-03

Review 8.  The effect of antihypertensive treatment on the quality of later years.

Authors:  M A James; J F Potter
Journal:  Drugs Aging       Date:  1993 Jan-Feb       Impact factor: 3.923

9.  SIRT1 promotes endothelium-dependent vascular relaxation by activating endothelial nitric oxide synthase.

Authors:  Ilwola Mattagajasingh; Cuk-Seong Kim; Asma Naqvi; Tohru Yamamori; Timothy A Hoffman; Saet-Byel Jung; Jeremy DeRicco; Kenji Kasuno; Kaikobad Irani
Journal:  Proc Natl Acad Sci U S A       Date:  2007-09-04       Impact factor: 11.205

10.  Therapeutic hypertension system based on a microbreathing pressure sensor system.

Authors:  Ziji Diao; Hongying Liu; Lan Zhu; Xiaoqiang Gao; Suwen Zhao; Xitian Pi; Xiaolin Zheng
Journal:  Med Devices (Auckl)       Date:  2011-05-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.